{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T20:26:38Z","timestamp":1776371198322,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,16]]},"DOI":"10.7759\/cureus.86107","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T07:27:24Z","timestamp":1750058844000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Ticagrelor Versus Clopidogrel in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Faisal","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Ashraf","family":"Abid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutva","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiza Zanish","family":"Iram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manpreet","family":"Kaur Dhanjal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandipkumar S","family":"Chaudhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Qasim","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamsha","family":"Hirani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints C","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, et al.. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024, 45:3415-537. 10.1093\/eurheartj\/ehae177","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-321870","article-title":"Role of percutaneous coronary intervention in the modern-day management of chronic coronary syndrome","volume":"109","author":"Cartlidge T","year":"2023","unstructured":"Cartlidge T, Kovacevic M, Navarese EP, Werner G, Kunadian V. Role of percutaneous coronary intervention in the modern-day management of chronic coronary syndrome. Heart. 2023, 109:1429-35. 10.1136\/heartjnl-2022-321870","journal-title":"Heart"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.818215","article-title":"Comparison of clinical outcomes between ticagrelor and clopidogrel in acute coronary syndrome: a comprehensive meta-analysis","volume":"8","author":"Sun M","year":"2021","unstructured":"Sun M, Cui W, Li L. Comparison of clinical outcomes between ticagrelor and clopidogrel in acute coronary syndrome: a comprehensive meta-analysis. Front Cardiovasc Med. 2021, 8:818215. 10.3389\/fcvm.2021.818215","journal-title":"Front Cardiovasc Med"},{"key":"ref4","article-title":"Dual antiplatelet therapy for the general cardiologist: recent evidence, balancing ischaemic and bleeding risk","author":"Ortega-Paz L","year":"2023","unstructured":"Ortega-Paz L, Cader A, Cigalini I, Giacoppo D. Dual antiplatelet therapy for the general cardiologist: recent evidence, balancing ischaemic and bleeding risk. Eur Soc Cardiol. 2023,","journal-title":"Eur Soc Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3283385420","article-title":"Clopidogrel pathway","volume":"20","author":"Sangkuhl K","year":"2010","unstructured":"Sangkuhl K, Klein TE, Altman RB. Clopidogrel pathway. Pharmacogenet Genom. 2010, 20:463-5. 10.1097\/FPC.0b013e3283385420","journal-title":"Pharmacogenet Genom"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2011.550573","article-title":"Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor","volume":"12","author":"Giorgi MA","year":"2011","unstructured":"Giorgi MA, Cohen Arazi H, Gonzalez CD, Di Girolamo G. Beyond efficacy: pharmacokinetic differences between clopidogrel, prasugrel and ticagrelor. Expert Opin Pharmacother. 2011, 12:1285-95. 10.1517\/14656566.2011.550573","journal-title":"Expert Opin Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097%2823%2901742-4","article-title":"Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes: results from a real-world registry","volume":"81","author":"Koshy AN","year":"2023","unstructured":"Koshy AN, Giustino G, Sartori S, et al.. Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes: results from a real-world registry. J Am Coll Cardiol. 2023, 81:10.1016\/S0735-1097%2823%2901742-4","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae666.1265","article-title":"Ticagrelor or prasugrel versus clopidogrel in patients with coronary heart disease","volume":"45","author":"Costa L","year":"2024","unstructured":"Costa L, Nunes RA, Scudeler TL, et al.. Ticagrelor or prasugrel versus clopidogrel in patients with coronary heart disease. Eur Heart J. 2024, 45:10.1093\/eurheartj\/ehae666.1265","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77610","article-title":"Evaluating the safety and efficacy of ticagrelor vs. clopidogrel following percutaneous coronary intervention in chronic coronary disease","volume":"17","author":"Rauf MA","year":"2025","unstructured":"Rauf MA, Ziyad M, Mahmood N, Ullah R, Ahmad F, Ullah I, Shah SM. Evaluating the safety and efficacy of ticagrelor vs. clopidogrel following percutaneous coronary intervention in chronic coronary disease. Cureus. 2025, 17:e77610. 10.7759\/cureus.77610","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2023.12.011","article-title":"Ticagrelor vs clopidogrel for complex percutaneous coronary intervention in chronic coronary syndrome","volume":"17","author":"Lattuca B","year":"2024","unstructured":"Lattuca B, Mazeau C, Cayla G, et al.. Ticagrelor vs clopidogrel for complex percutaneous coronary intervention in chronic coronary syndrome. JACC Cardiovasc Interv. 2024, 17:359-70. 10.1016\/j.jcin.2023.12.011","journal-title":"JACC Cardiovasc Interv"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5551\/jat.57265","article-title":"Efficacy and safety of ticagrelor and clopidogrel in patients with stable coronary artery disease undergoing percutaneous coronary intervention","volume":"28","author":"Li J","year":"2021","unstructured":"Li J, Qiu H, Yan L, et al.. Efficacy and safety of ticagrelor and clopidogrel in patients with stable coronary artery disease undergoing percutaneous coronary intervention. J Atheroscler Thromb. 2021, 28:873-82. 10.5551\/jat.57265","journal-title":"J Atheroscler Thromb"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.768190","article-title":"Ticagrelor vs. clopidogrel after complex percutaneous coronary intervention in patients with stable coronary artery disease","volume":"8","author":"Xi Z","year":"2021","unstructured":"Xi Z, Li J, Qiu H, et al.. Ticagrelor vs. clopidogrel after complex percutaneous coronary intervention in patients with stable coronary artery disease. Front Cardiovasc Med. 2021, 8:768190. 10.3389\/fcvm.2021.768190","journal-title":"Front Cardiovasc Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2024.10.007","article-title":"Comments on the ESC 2024 guidelines for the management of chronic coronary syndromes","volume":"78","author":"Vivas D","year":"2025","unstructured":"Vivas D. Comments on the ESC 2024 guidelines for the management of chronic coronary syndromes. Rev Esp Cardiol (Engl Ed). 2025, 78:170-5. 10.1016\/j.rec.2024.10.007","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.24969\/hvt.2024.508","article-title":"Chronic coronary syndromes: diagnosis, management and gaps in evidence","volume":"8","author":"Mafrica D","year":"2024","unstructured":"Mafrica D, Franculli G, Esposito A, Sarto G, Sabouret P, Biondi-Zoccai G, Bernardi M. Chronic coronary syndromes: diagnosis, management and gaps in evidence. Heart, Vessels Transplant. 2024, 8:391-410. 10.24969\/hvt.2024.508","journal-title":"Heart, Vessels Transplant"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines","volume":"148","author":"Virani SS","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV, et al.. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines. Circulation. 2023, 148:e9-e119. 10.1161\/CIR.0000000000001168","journal-title":"Circulation"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46455","article-title":"Efficacy and safety profile of ticagrelor versus clopidogrel in percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS): a systematic review and meta-analysis","volume":"15","author":"Maqbool S","year":"2023","unstructured":"Maqbool S, Ali MS, Rehman A, et al.. Efficacy and safety profile of ticagrelor versus clopidogrel in percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS): a systematic review and meta-analysis. Cureus. 2023, 15:e46455. 10.7759\/cureus.46455","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-23-00427","article-title":"De-escalation from ticagrelor to clopidogrel in patients with acute myocardial infarction: the TALOS-AMI HBR substudy","volume":"19","author":"Kim MC","year":"2023","unstructured":"Kim MC, Ahn SG, Cho KH, et al.. De-escalation from ticagrelor to clopidogrel in patients with acute myocardial infarction: the TALOS-AMI HBR substudy. EuroIntervention. 2023, 19:e832-43. 10.4244\/EIJ-D-23-00427","journal-title":"EuroIntervention"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5551\/jat.40584","article-title":"Antiplatelet therapy in ACS patients: comparing appropriate P2Y12 inhibition by clopidogrel to the use of new P2Y12 inhibitors","volume":"25","author":"Ristorto J","year":"2018","unstructured":"Ristorto J, Messas N, Marchandot B, et al.. Antiplatelet therapy in ACS patients: comparing appropriate P2Y12 inhibition by clopidogrel to the use of new P2Y12 inhibitors. J Atheroscler Thromb. 2018, 25:674-89. 10.5551\/jat.40584","journal-title":"J Atheroscler Thromb"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000000390","article-title":"Assessment of ticagrelor versus clopidogrel treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"68","author":"Tang X","year":"2016","unstructured":"Tang X, Li R, Jing Q, Wang Q, Liu P, Zhang P, Liu Y. Assessment of ticagrelor versus clopidogrel treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Cardiovasc Pharmacol. 2016, 68:115-20. 10.1097\/FJC.0000000000000390","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001039","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Lawton JS","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, et al.. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022, 145:e4-e17. 10.1161\/CIR.0000000000001039","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","author":"Valgimigli M","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA, et al.. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018, 39:213-60. 10.1093\/eurheartj\/ehx419","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/373265-efficacy-and-safety-of-ticagrelor-versus-clopidogrel-in-patients-with-chronic-coronary-syndrome-undergoing-percutaneous-coronary-intervention-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T07:27:25Z","timestamp":1750058845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/373265-efficacy-and-safety-of-ticagrelor-versus-clopidogrel-in-patients-with-chronic-coronary-syndrome-undergoing-percutaneous-coronary-intervention-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.86107","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,16]]}}}